e-SPACE Cardio-Renal-Metabolic 2023
Published: 25 March 2023
-
Views:
13290 -
Likes:
7
-
Views:
13290 -
Likes:
7
-
Up Next
-
58m 41sPart 1 | Session 8 Plenary session 5 – Mineralocorticoids antagonists in CRM disease
-
25m 15s
-
59m 5sPart 1 | Session 10 Plenary session 6 – Diuretics: old drugs, new data, new approaches
-
1h 20s
-
43m 41s
-
1h 10s
-
31m 5s
-
59m 17sPart 2 | Session 5 Plenary session 9 – Managing “metals”
-
41m 30s
-
1h 2m 16sPart 2 | Session 7 Plenary session 10 – Management of diabetes with kidney disease
-
1h 3m 10sPart 2 | Session 8 Plenary session 11 – Managing frail and elderly patients
-
1h 1m 47sPart 2 | Session 9 Plenary session 12 – Managing end-stage disease: focus on QoL
-
58m 8sPart 1 | Session 1 Plenary session 1 – HFpEF Andrew JS Coats, Giuseppe Rosano, Eberhard Standl, María José Soler, Stefan Anker
-
51m 57sPart 1 | Session 2 Satellite symposium – SGLT2 inhibitors in cardio-renal-metabolic patients – the perfect fit? (Supported by an educational grant from the Boehringer Ingelheim & Lilly Alliance) Stefan Anker, Paola Fioretto, Michel Jadoul
-
56m 38sPart 1 | Session 3 Plenary session 2 – SGLT2 updates Andrew JS Coats, Hiddo Lambers Heerspink, Antonio Ceriello, Gianluigi Savarese, Christoph Wanner
-
31m 38sPart 1 | Session 4 Meet the expert – Management of heart failure in real world clinical practice – insights from the REWOLUTION HF surveys Ewa Jankowska, Andrew JS Coats
-
58m 54sPart 1 | Session 5 Plenary session 3 – Weight management in CRM disease Luc Van Gaal, Wolfram Doehner, Milton Packer, Carel le Roux, Tammy Lyn Kindel, Ildiko Lingvay
-
30m 11sPart 1 | Session 6 Meet the expert – Implementation patterns and challenges in HF care: insights from the EVOLUTION HF study (Supported by an educational grant from AstraZeneca) Orly Vardeny, Gianluigi Savarese
Overview
e-SPACE Cardio-Renal-Metabolic 2023 was the third edition of the annual global online conference that explores how leading experts, in cardiology, nephrology, and diabetology, are treating the interrelated diseases.
Course leadership Prof Stefan Anker (Berlin, DE), Dr Javed Butler (Texas, US), Prof Antonio Ceriello (Milan, IT), Prof Tara I Chang (California, US), Prof Ian de Boer (Washington, US), Prof Peter Rossing (Copenhagen, DK) and Prof Shelley Zieroth (Winnipeg, CA) lead an interactive programme of plenary sessions, meet the expert, case discussions and satellite symposium sessions focusing on the patient journey.
For the first time, e-SPACE Cardio-Renal-Metabolic 2023 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality, and reduced quality of life affecting individuals around the world
- Describe the complexity and interlink between the three conditions
- Discuss existing guidelines and best approaches for screening patients
- Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
- Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes
Target Audience
- Cardiologists
- Nephrologists
- Diabetologists
- General Practitioners (GPs)
- HF Specialists
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Stephan Von Haehling
Professor of Cardiology and Consultant Cardiologist
Prof Stephan von Haehling is a Professor of Cardiology and Consultant Cardiologist at University Medicine Göttingen, Göttingen, DE.
His PhD was awarded by Imperial College, London, UK after he completed studies on inflammatory mechanisms of heart failure at the National Heart and Lung Institute in London.
Prof von Haehling is a Fellow of the European Society of Cardiology and of the Heart Failure Association of the ESC. His research interests include the pathophysiology and the co-morbidities of heart failure, with particular focus on muscle wasting, biomarkers, and novel treatments.
Mehriban Isgandar
Scientific Fellow
Dr Mehriban Isgandar is a Scientific Fellow at Azerbaijan Medical University, Baku, AZ and a Consultant Cardiologist.
She is a Fellow of the Azerbaijan Society of Cardiology and also a HFA Young Ambassador (2023-2024).
Alexandre Mebazaa
Professor of Medicine
Prof Alexandre Mebazaa is a Professor of Medicine at Paris Cité University, Paris, FR.
He is also Director of INSERM Unit 942 Mascot and Chair of Department of Anesthesia & Critical Care, Paris, FR.
Prof Mebazaa leads a large research group on biomarkers and biotherapies in critical conditions, named MASCOT granted by the Université de Paris Cité and Inserm. He is part of the task force that wrote the 2021 ESC / HFA Guidelines of Heart Failure and the 2023 addendum.
Adriaan Voors
Professor of Cardiology
Prof Adriaan Voors is a Professor of Cardiology at University Medical Center Groningen, Groningen, NL.
In 2007, he became Established Clinical Investigator of the Netherlands Heart Foundation.
Prof Voors is an editorial board member of the European Journal of Heart Failure, Clinical Research in Cardiology, Cardiovascular Drugs and Therapy, the Journal of Cardiovascular Medicine, and Heart Failure Reviews.
Marat Fudim
Assistant Professor
Dr Marat Fudim is a cardiologist, advanced heart failure specialist and assistant professor at Duke University, Durham, US. He has a clinical and research interest in heart failure, including advanced therapies such as mechanical assist devices or "heart pumps" and heart transplantation.
As part of his work, Dr Fudim also performs cardiac catheterizations to understand a patient’s disease.
Vijay Chopra
Senior Director of Clinical Cardiology, Heart Failure and Research
Dr Vijay Chopra is the Senior Director of Clinical Cardiology, Heart Failure and Research in the Heart Failure Programme at the Max Super Specialty Hospital in Saket, New Delhi, India. He is considered a pioneer in preventive cardiology, and has worked extensively in the management of patients with advanced heart disease. He has been principal investigator of numerous international clinical trials.
Dr Chopra's research interests include preventive cardiology, heart failures and advanced heart diseases. He was awarded the Kutumbiah Prize in Clinical Medicine from CMC Vellore in 1972. He founded the Heart Failure Association of India (HFAI), and served as its first president from 2014 - 2019.
Dr Chopra has over 50 publications in peer-reviewed journals.
Dr Vijay Chopra is an Editorial Board member of Cardiac Failure Review and may be contacted
Comments